{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:13:49Z","timestamp":1790118829706,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heart transplantation is often an unrealizable therapeutic option for end-stage heart failure, which is why mechanical left ventricular assist devices (LVADs) become an increasingly important therapeutic alternative. Currently, there is a lack of information about molecular mechanisms which are influenced by LVADs, particularly regarding the pathophysiologically critical renin angiotensin system (RAS). We, therefore, determined regulation patterns of key components of the RAS and the \u03b2-arrestin signaling pathways in left ventricular (LV) tissue specimens from 8 patients with end-stage ischemic cardiomyopathy (ICM) and 12 patients with terminal dilated cardiomyopathy (DCM) before and after LVAD implantation and compared them with non-failing (NF) left ventricular tissue samples: AT1R, AT2R, ACE, ACE2, MasR, and ADAM17 were analyzed by polymerase chain reaction. ERK, phosphorylated ERK, p38, phosphorylated p38, JNK, phosphorylated JNK, GRK2, \u03b2-arrestin 2, PI3K, Akt, and phosphorylated Akt were determined by Western blot analysis. Angiotensin I and Angiotensin II were quantified by mass spectrometry. Patients were predominantly middle-aged (53\u2009\u00b1\u200910\u00a0years) men with severely impaired LV function (LVEF 19\u2009\u00b1\u20098%), when receiving LVAD therapy for a mean duration of 331\u2009\u00b1\u2009317\u00a0days. Baseline characteristics did not differ significantly between ICM and DCM patients. By comparing failing with non-failing left ventricles, i.e., before LVAD implantation, a downregulation of AT1R, AT2R, and MasR and an upregulation of ACE, ACE2, GRK, \u03b2-arrestin, ERK, PI3K, and Akt were seen. Following LVAD support, then angiotensin I, ACE2, GRK, and \u03b2-arrestin were downregulated and AT2R, JNK, and p38 were upregulated. ACE, angiotensin II, AT1R, ADAM17, MasR, ERK, PI3K, and Akt remained unchanged. Some regulation patterns were influenced by the underlying etiology of heart failure, the severity of LV dysfunction at baseline, and the duration of LVAD therapy. Key components of the RAS and \u03b2-arrestin signaling pathways were divergently altered in failing left ventricles both before and after LVAD implantation, whereas a remarkable fraction remained unchanged. This indicates a rather incomplete molecular reverse remodeling, whose functional relevance has to be further evaluated.<\/jats:p>","DOI":"10.1007\/s11010-020-03787-7","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T21:02:17Z","timestamp":1592686937000},"page":"79-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Alterations of the renin angiotensin system in human end-stage heart failure before and after mechanical cardiac unloading by LVAD support"],"prefix":"10.1007","volume":"472","author":[{"given":"Rebecca","family":"Messmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dietl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Jungbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Luchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars S.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Schopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-9442","authenticated-orcid":false,"given":"Christoph","family":"Birner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"issue":"5","key":"3787_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/hrt.2006.098814","volume":"93","author":"EB Friedrich","year":"2007","unstructured":"Friedrich EB, B\u00f6hm M (2007) Management of end stage heart failure. Heart 93(5):626\u2013631. https:\/\/doi.org\/10.1136\/hrt.2006.098814","journal-title":"Heart"},{"issue":"5","key":"3787_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3978\/j.issn.2225-319X.2014.08.20","volume":"3","author":"T Puehler","year":"2014","unstructured":"Puehler T, Ensminger S, Schoenbrodt M et al (2014) Mechanical circulatory support devices as destination therapy-current evidence. Ann Cardiothorac Surg 3(5):513\u2013524. https:\/\/doi.org\/10.3978\/j.issn.2225-319X.2014.08.20","journal-title":"Ann Cardiothorac Surg"},{"issue":"10","key":"3787_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","volume":"36","author":"LH Lund","year":"2017","unstructured":"Lund LH, Khush KK, Cherikh WS et al (2017) The registry of the international society for heart and lung transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 36(10):1037\u20131046. https:\/\/doi.org\/10.1016\/j.healun.2017.07.019","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"3787_CR4","first-page":"552","volume":"38","author":"EJ Birks","year":"2011","unstructured":"Birks EJ (2011) A changing trend toward destination therapy: are we treating the same patients differently? Tex Heart Inst J 38(5):552\u2013554","journal-title":"Tex Heart Inst J"},{"issue":"10","key":"3787_CR5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","volume":"36","author":"JK Kirklin","year":"2017","unstructured":"Kirklin JK, Pagani FD, Kormos RL et al (2017) Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 36(10):1080\u20131086. https:\/\/doi.org\/10.1016\/j.healun.2017.07.005","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"3787_CR6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s00380-018-1149-x","volume":"33","author":"S Persoon","year":"2018","unstructured":"Persoon S, Paulus M, Hirt S et al (2018) Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy. Heart Vessels 33(8):948\u2013957. https:\/\/doi.org\/10.1007\/s00380-018-1149-x","journal-title":"Heart Vessels"},{"issue":"19 Suppl","key":"3787_CR7","first-page":"216","volume":"100","author":"B Bartling","year":"1999","unstructured":"Bartling B, Milting H, Schumann H et al (1999) Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 100(19 Suppl):216\u2013223","journal-title":"Circulation"},{"issue":"4","key":"3787_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2004.05.049","volume":"44","author":"KW Chaudhary","year":"2004","unstructured":"Chaudhary KW, Rossman EI, Piacentino V et al (2004) Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart. J Am Coll Cardiol 44(4):837\u2013845. https:\/\/doi.org\/10.1016\/j.jacc.2004.05.049","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3787_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/01.cir.100.11.1189","volume":"100","author":"G Torre-Amione","year":"1999","unstructured":"Torre-Amione G, Stetson SJ, Youker KA et al (1999) Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100(11):1189\u20131193. https:\/\/doi.org\/10.1161\/01.cir.100.11.1189","journal-title":"Circulation"},{"issue":"9","key":"3787_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/eurjhf\/hft059","volume":"15","author":"RS George","year":"2013","unstructured":"George RS, Birks EJ, Cheetham A et al (2013) The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 15(9):1035\u20131043. https:\/\/doi.org\/10.1093\/eurjhf\/hft059","journal-title":"Eur J Heart Fail"},{"key":"3787_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd6020014","author":"A Nehme","year":"2019","unstructured":"Nehme A, Zouein FA, Zayeri ZD et al (2019) An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis. https:\/\/doi.org\/10.3390\/jcdd6020014","journal-title":"J Cardiovasc Dev Dis"},{"issue":"5","key":"3787_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd3024","volume":"9","author":"S Rajagopal","year":"2010","unstructured":"Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9(5):373\u2013386. https:\/\/doi.org\/10.1038\/nrd3024","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"3787_CR13","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.jacc.2018.08.2186","volume":"72","author":"TE Sharp","year":"2018","unstructured":"Sharp TE, Polhemus DJ, Li Z et al (2018) Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system. J Am Coll Cardiol 72(21):2609\u20132621. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.2186","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3787_CR14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/01.cir.95.5.1193","volume":"95","author":"K Asano","year":"1997","unstructured":"Asano K, Dutcher DL, Port JD et al (1997) Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 95(5):1193\u20131200. https:\/\/doi.org\/10.1161\/01.cir.95.5.1193","journal-title":"Circulation"},{"issue":"5","key":"3787_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/01.cir.91.5.1461","volume":"91","author":"V Regitz-Zagrosek","year":"1995","unstructured":"Regitz-Zagrosek V, Friedel N, Heymann A et al (1995) Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91(5):1461\u20131471. https:\/\/doi.org\/10.1161\/01.cir.91.5.1461","journal-title":"Circulation"},{"issue":"2","key":"3787_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.peptides.2012.03.022","volume":"35","author":"MF Dias-Peixoto","year":"2012","unstructured":"Dias-Peixoto MF, Ferreira AJ, Almeida PWM et al (2012) The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli. Peptides 35(2):196\u2013201. https:\/\/doi.org\/10.1016\/j.peptides.2012.03.022","journal-title":"Peptides"},{"issue":"1","key":"3787_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0008-6363(00)00008-0","volume":"46","author":"T Matsumoto","year":"2000","unstructured":"Matsumoto T (2000) Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure. Cardiovasc Res 46(1):73\u201381. https:\/\/doi.org\/10.1016\/S0008-6363(00)00008-0","journal-title":"Cardiovasc Res"},{"issue":"20","key":"3787_CR18","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC et al (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111(20):2605\u20132610. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.510461","journal-title":"Circulation"},{"issue":"7","key":"3787_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.cir.98.7.656","volume":"98","author":"A Zafeiridis","year":"1998","unstructured":"Zafeiridis A, Jeevanandam V, Houser SR et al (1998) Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98(7):656\u2013662. https:\/\/doi.org\/10.1161\/01.cir.98.7.656","journal-title":"Circulation"},{"issue":"5","key":"3787_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacc.2003.09.052","volume":"43","author":"M Vatta","year":"2004","unstructured":"Vatta M, Stetson SJ, Jimenez S et al (2004) Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol 43(5):811\u2013817. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.052","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3787_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/s1053-2498(00)00321-1","volume":"20","author":"BA Bruckner","year":"2001","unstructured":"Bruckner BA, Stetson SJ, Perez-Verdia A et al (2001) Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transpl 20(4):457\u2013464. https:\/\/doi.org\/10.1016\/s1053-2498(00)00321-1","journal-title":"J Heart Lung Transpl"},{"issue":"1 Suppl","key":"3787_CR22","doi-asserted-by":"publisher","first-page":"I16","DOI":"10.1161\/CIRCULATIONAHA.105.000448","volume":"114","author":"ME Cullen","year":"2006","unstructured":"Cullen ME, Yuen AHY, Felkin LE et al (2006) Myocardial expression of the arginine: glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 114(1 Suppl):I16\u201320. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.000448","journal-title":"Circulation"},{"issue":"3","key":"3787_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1152\/physiolgenomics.00022.2003","volume":"14","author":"Y Chen","year":"2003","unstructured":"Chen Y, Park S, Li Y et al (2003) Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 14(3):251\u2013260. https:\/\/doi.org\/10.1152\/physiolgenomics.00022.2003","journal-title":"Physiol Genomics"},{"issue":"3","key":"3787_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1152\/physiolgenomics.00004.2004","volume":"17","author":"JL Hall","year":"2004","unstructured":"Hall JL, Grindle S, Han X et al (2004) Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17(3):283\u2013291. https:\/\/doi.org\/10.1152\/physiolgenomics.00004.2004","journal-title":"Physiol Genomics"},{"issue":"Suppl 2","key":"3787_CR25","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1055\/s-0029-1240709","volume":"58","author":"H Welp","year":"2010","unstructured":"Welp H, Rukosujew A, Tjan TDT et al (2010) Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg 58(Suppl 2):S185\u2013S188. https:\/\/doi.org\/10.1055\/s-0029-1240709","journal-title":"Thorac Cardiovasc Surg"},{"issue":"7","key":"3787_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/eurheartj\/ehp012","volume":"30","author":"S Klotz","year":"2009","unstructured":"Klotz S, Burkhoff D, Garrelds IM et al (2009) The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur Heart J 30(7):805\u2013812. https:\/\/doi.org\/10.1093\/eurheartj\/ehp012","journal-title":"Eur Heart J"},{"issue":"2","key":"3787_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0008-6363(03)00393-6","volume":"59","author":"H Baba","year":"2003","unstructured":"Baba H, Stypmann J, Grabellus F et al (2003) Dynamic regulation of MEK\/Erks and Akt\/GSK-3?: in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res 59(2):390\u2013399. https:\/\/doi.org\/10.1016\/s0008-6363(03)00393-6","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3787_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000072387","volume":"100","author":"P Razeghi","year":"2003","unstructured":"Razeghi P, Bruckner BA, Sharma S et al (2003) Mechanical unloading of the failing human heart fails to activate the protein kinase B\/Akt\/glycogen synthase kinase-3beta survival pathway. Cardiology 100(1):17\u201322. https:\/\/doi.org\/10.1159\/000072387","journal-title":"Cardiology"},{"issue":"6","key":"3787_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/CIRCRESAHA.113.301413","volume":"113","author":"EJ Birks","year":"2013","unstructured":"Birks EJ (2013) Molecular changes after left ventricular assist device support for heart failure. Circ Res 113(6):777\u2013791. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301413","journal-title":"Circ Res"},{"issue":"4","key":"3787_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/CIRCHEARTFAILURE.112.000255","volume":"6","author":"SI Lok","year":"2013","unstructured":"Lok SI, van Mil A, Bovenschen N et al (2013) Post-transcriptional regulation of \u03b1-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical support. Circ Heart Fail 6(4):853\u2013861. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000255","journal-title":"Circ Heart Fail"},{"issue":"1","key":"3787_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.healun.2003.10.016","volume":"24","author":"A Rodrigue-Way","year":"2005","unstructured":"Rodrigue-Way A, Burkhoff D, Geesaman BJ et al (2005) Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transpl 24(1):73\u201380. https:\/\/doi.org\/10.1016\/j.healun.2003.10.016","journal-title":"J Heart Lung Transpl"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03787-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-020-03787-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03787-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T23:06:57Z","timestamp":1624144017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-020-03787-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03787-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"30 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they do not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}